Table 3.

Effects of ESZWD on cardiac function of CHF-HKYd rats.

	IVSd/mm	LVIDd/mm	LVPWd/mm	IVSs/mm	LVIDs/mm	SV/mL	LVEF%	FS%	LVPWs/mm	E/A
Normal	1.213 ± 0.29	5.288 ± 0.52	1.650 ± 0.37	2.538 ± 0.86	2.363 ± 0.81	0.3138 ± 0.09	88.64 ± 9.03	57.53 ± 15.98	1.685 ± 0.25	1.542 ± 0.15
Model	1.643 ± 0.27#	6.129 ± 0.33#	1.671 ± 0.22	2.243 ± 0.38	3.757 ± 0.70##	0.3929 ± 0.07	73.55 ± 12.7##	38.73 ± 9.89##	1.891 ± 0.10	0.729 ± 0.12#
ESZWD-L	2.033 ± 0.58	5.633 ± 0.25*	2.000 ± 0.36	3.067 ± 0.25	3.433 ± 0.67	0.3100 ± 0.09*	76.99 ± 16.0	38.65 ± 13.4	2.667 ± 0.45	1.863 ± 0.43*
ESZWD-M	1.817 ± 0.57	5.450 ± 0.63*	2.017 ± 0.38	2.767 ± 0.30	2.900 ± 0.87*	0.3183 ± 0.08	82.41 ± 9.61	47.66 ± 12.2	3.033 ± 0.66**	2.013 ± 0.42*
ESZWD-H	1.433 ± 0.12	6.133 ± 0.80	1.733 ± 0.35	2.367 ± 0.23	3.60 ± 0.56	0.4767 ± 0.22	84.37 ± 8.85	49.65 ± 12.4	2.933 ± 0.68*	1.976 ± 0.36*
Benazepril	1.800 ± 0.62	5.950 ± 1.28	1.900 ± 0.67	3.425 ± 0.88	2.350 ± 0.72**	0.4950 ± 0.25	92.30 ± 4.09**	60.31 ± 8.10**	3.525 ± 0.79**	1.794 ± 0.28*

Compared with control group,

^#P < 0.05,

^##P < 0.01, difference has significance; Compared with model group,

^*P < 0.05,

^**P < 0.01, difference has significance.